Emerging Therapy

Emerging Therapy

Patent Issued for Innovative Auto-Injector Mechanism

Does this portend an auto-injector with a longer shelf-life, impervious to temperature changes, and the size of a USB thumb-drive that could be carried on a key chain?
Oval Auto-Injector

Recap: Four Auto-Injectors on the Horizon

Here are articles we published in the past year on four noteworthy auto-injector designs currently at various stages in the pipeline.
Skin Prick Testing

Food Allergy Immunotherapy Advances Presented at AAAAI Meeting

Here's a quick recap from this morning's AAAAI press release.
Oval Auto-Injector

Medical Device Company Tests Compact Auto-Injector Design

The firm is currently in the early stages of testing the design of a new, compact auto-injector which the company estimates may hit the UK market in 2019.
Afrezza Inhalable Insulin Device

Pharmaceutical Company Developing Inhalable Epinephrine

MannKind Corporation is developing a product that would dispose of the needle entirely.

Viaskin Peanut Patch: Lasting Response After Three Years

Pediatric patients responded with a favorable safety profile and no serious adverse effects.

FDA Provides Primer on Current State of Allergy Immunotherapies

We provide a summary for individuals new to the world of food allergies and therapies under investigation.

Aptar Pharma and BD Announce Deal to Bring New Auto-Injector to Market

The economies of scale of the device's multiple applications could potentially result in a lower cost alternative for epinephrine delivery.

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Antibody targets trigger also implicated in other food allergies, atopic diseases, and asthma.

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the AAAAI Conference

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Connect with Us

27,828FansLike
85FollowersFollow
3,884FollowersFollow
30SubscribersSubscribe